Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 11/05/2021

20191453 - idea concept with light bulbs and energy save bulb green background

Debbie Rigby takes a look at the latest in research news Inhaled budesonide in the treatment of early COVID-19 (STOIC) A randomised controlled trial (Steroids in COVID-19; STOIC) of inhaled budesonide, compared with usual care, in adults within 7 days of the onset of mild COVID-19 symptoms has shown that early administration of inhaled budesonide

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Thank you’: How I saved a patient’s life with naloxone

You are right Adam it is absorbed orally and undergoes extensive first pass . Contraindicated in hepatic disease .

Michael Post

Patients back scope expansion

Ben, Hx and exam is a minimum 4 year medical degree. It takes many years of tertiary experience to learn…

Michael Post

CWH founders building a business for their ‘kids and grandkids’

“We need to move from a non-sophisticated business model to one with corporate governance. ... see that , I don't…

Ahmad Hawwari

CWH founders building a business for their ‘kids and grandkids’

Mmm doubt that , if CWH continue like this more influential people will have interest to lobby the government as…

Ahmad Hawwari

Research Roundup

Previous Here's what you said

Next Making an impact

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Here's what you said

Next Making an impact

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.